The activities and subcellular localization of cathepsin B and cysteine proteinase inhibitors in human ovarian carcinoma

• Autorzy: Haczynska H. , Gerber J. , Osada J. , Warwas M.
• Języki publikacji: EN

Abstrakty

EN

Ovarian carcinomas exhibited a higher cathepsin B activity than did normal ovaries. The plasma membrane fractions of ovarian cancers were enriched in the activities of both cathepsin and cysteine proteinase inhibitors. The ratio of cathepsin to the inhibitors in these fractions was higher at stage IV than at stage III of the disease, classified according to the Federation of International Gynecology and Obstetrics.

Słowa kluczowe

EN

plasma membrane; man; ovarian cancer; cysteine proteinase inhibitor; ovarian carcinoma; cystatin; cathepsin B

• Wydawca: -
• Czasopismo: Acta Biochimica Polonica
• Rocznik: 1997
• Tom: 44
• Numer: 1
• Opis fizyczny: p.113-120,fig.

Twórcy

autor

Haczynska H.

• Wroclaw University of Medicine, Szewska 38-39, 50-139 Wroclaw, Poland

autor

Gerber J.

autor

Osada J.

autor

Warwas M.

Bibliografia

• 1. Aznavoorian, S., Murphy, AN., Stetler-Ste- venson, W.G. & Liotta, L.A. (1993) Molecular aspects of tumor cell invasion and metastasis. Cancer 71, 1368-1383.
• 2. Sloane, B.F., Moin, K., Krepela, E. & Rozhin, J. (1990) Cathepsin B and its endogenous inhibitors: The role in tumor malignancy. Cancer Metastasis Rev. 9, 333-352.
• 3. Kobayashi, H., Moniwa, N., Sugimura, M., Shinohara, H., Ohi, H. & Terao, T. (1993) Effects of membrane-associated cathepsin B on the activation of receptor-bound prouroki- nasc and subsequent invasion of reconsti­tuted basement membranes. Biochim. Bio- phys. Acta 1178, 55-62.
• 4. Kobayashi, H., Ohi, H., Sugimura, M., Shino­hara, H., Fujii, T. & Terao, T. (1992) Inhibi­tion of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B. Cancer Res. 52, 3610-3614.
• 5. Schmalfeldt, B., Kuhn, W., Reuning, U., Pache, L., Dettmar, P., Schmitt, M., Janicke, F., Hofler, H. & Graeff, H. (1995) Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasmino­gen activator, its receptor, and inhibitors types 1 and 2. Cancer Res. 55, 3958-3963.
• 6. Keppler, D., Abrahamson, M. & Sordat, B. (1994) Secretion of cathepsin B and tumour invasion. Biochem. Soc. Trans. 22, 43-49.
• 7. Keppler, D., Waridel, P., Abrahamson, M., Bachmann, D., Berdoz, J. & Sordat, B. (1994) Latency of cathepsin B secreted by human colon carcinoma cells is not linked to secretion of cystatin C and is relieved by neutrophil elastase. Biochim. Biophys. Acta 1226, 117— 125.
• 8. Calkins, C.C. & Sloane, B.F. (1995) Mammal­ian cysteine protease inhibitors: Biochemical properties and possible roles in tumor pro­gression. Biol. Chem. Hoppe-Seyler 376, 71- 80.
• 9. Lah, T.T., Kokalj-Kunovar, M., Kastelic, L., Babnik, J., Stolfa, A, Rainer, S. & Turk, V. (1991) Cystatins and stefins in ascites fluid from ovarian carcinoma. Cancer Lett. 61, 243-253.
• 10. Rozhin, J., Robinson, D., Stevens, M.A., Lah, T.T., Honn, K.V., Ryan, R.E. & Sloane, B.F. (1987) Properties of a plasma membrane-as- sociated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants. Cancer Res. 47, 6620-6628.
• 11. Barrett, A.J., Kembhavi, A.A., Brown, MA, Kirschke, H., Knight, C.G., Tamai, M. & Ha- nada, K (1982) L-7Vans-epoxysuccinyl-leucyl- amido (4-guanidino) butane (E-64) and its analogues as inhibitors of cysteine proteina­ses including cathepsin B, H and L. Biochem. J. 201, 189-198.
• 12. Jorgensen, P.L. (1974) Isolation of Na\K*- ATPase. Methods Enzymol. 32B. 277-290.
• 13. Fischman, W.H. (1970) P-Glucuronidase; in Methoden der Enzymatischen Analyse (Berg- meyer, H., ed.) pp. 865-888, Verlag Chemie, Weinheim.
• 14. Barrett, A.J. & Kirschke, H. (1981) Methods Enzymol. 80, 535-561.
• 15. Bradford, M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248- 254.
• 16. Lah, T.T., Calaf, G., Kalman, E., Shinde, B.G., Russo, J., Jarosz, D., Zabrecky, J., Somers, R. & Daskal. I. (1995) Cathepsin D, B, and L in breast carcinoma and in transformed human breast epithelial cells (HBEC). Biol. Chem. Hoppe-Seyler 376, 357-363.
• 17. Makarewicz, R., Drewa, G., Szymanski, W. & Skonieczna-Makarewicz, I. (1995) Cathepsin B in predicting the extent of the cervix carci­noma. Neoplasma 42, 21-24.
• 18. Adenis, A., Huet, G., Zerimech, F., Hecquct, B., Balduyck, M. & Peyrat, J.P. (1995) Cathe­psin B, L, and D activities in colorectal carci­nomas: Relationship with clinico-pathological parameters. Cancer Lett. 96, 267-275.
• 19. Knoch, H., Wcrle, B., Ebert, W. & Spiess, E. (1994) Imbalance between cathepsin B and cysteine proteinase inhibitors is of prognostic significance in human lung cancer. Int. J. Oncol. 5, 77-85.
• 20. Chung, S.M. & Kawai, K. (1990) Protease activities in gastric cancer tissues. Clin. Chim. Acta 189, 205-210.
• 21. Ohta, T., Terada, T., Nagakawa, T., Tajima, H., Itoh, H., Fonseca, L. & Miyazaki, I. (1994) Pancreatic trypsinogen and cathepsin B in human pancreatic carcinomas and associated metastatic lesions. Br. J. Cancer 69,152-156.
• 22. Sinha, A.A., Wilson, M.J., Gleason, D.F., Red- dy, P.K, Sameni, M. & Sloane, B.F. (1995) Immunohistochemical localization of cathep­sin B in neoplastic human prostate. Prostate 26, 171-178.
• 23. Sivaparvathi, M., Sawaya, R., Wang, S.W., Rayford, A., Yamamoto, M., Liotta, L.A., Ni- colson, G.L. & Rao, J.S. (1995) Overexpres- sion and localization of cathepsin B during the progression of human gliomas. Clin. Exp. Metastasis 13, 49-56.
• 24. Yoshii, A., Kageshita, T., Tsushima, H. & Ono, T. (1995) Clinical relevance of cathepsin B-like enzyme activity and cysteine protei­nase inhibitor in melanocytic tumours. Arch. Dermatol. Res. 287, 209-213.
• 25. Kastelic, L., Turk, B., Kopitar-Jcrala, N., Stol- fa, A., Rainer, S., Turk, V. & Lah, T.T. (1994) Stefin B, the major low molecular weight inhibitor in ovarian carcinoma. Cancer Lett. 82, 81-88.
• 26. Schwartz, M.K. (1995) Tissue cathepsins as tumor markers. Clin. Chim. Acta 237, 67-78.
• 27. Moin, K., Day, NA, Sameni, M., Hasnain, S., Hirama, T. & Sloane, B.F. (1992) Human tumour cathepsin B. Biochem. J. 285, 427- 434.
• 28. Rozhin, J., Gomez, A.P., Ziegler, G.H., Nelson, K.K., Chang, Y.S., Fong, D., Onoda, J.M., Honn, K.V. & Sloane, B.F. (1990) Cathepsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulations isolated from murine tumors. Cancer Res. 50, 6278-6284.
• 29. Sloane, B.F., Rozhin, J., Robinson, D. & Honn, K.V. (1990) Role for cathepsin B and cystatins in tumor growth and progression. Biol. Chem. Hoppe-Seyler 371, 193-198.30. Moin, K., Emmert, L.T. & Sloane, B.F. (1992) A membrane-associated cysteine protease inhibitor from murine hepatoma. FEBS Lett. 309, 279-282.